AIC-813

N/A

Report date: 2024/12/10 15:08:59
NME

Base Information

Drug NameAIC-813
Drug Alias NameHCMV therapeutics - AiCuris
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman cytomegalovirus tripartite terminas inhibitors
TargetsHuman cytomegalovirus tripartite terminas
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAicuris
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & CoAicuris
Active IndicationsN/A
Inactive IndicationsCytomegalovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A